Related Experiment Video
Updated: Jun 20, 2026
08:31
A Simplified Stepwise Approach to Echo Guidance during Percutaneous Mitral Valve Repair
Published on: October 16, 2021
Mitral stenosis.
Y Chandrashekhar1, Stephen Westaby, Jagat Narula
1Veterans Affairs Medical Center and University of Minnesota, Minneapolis, MN 55417, USA. shekh003@umn.edu
Lancet (London, England)
|September 15, 2009
Summary
Mitral stenosis, a prevalent heart valve disease, causes significant illness globally. Treatments improving valve area reduce morbidity, with surgery improving survival; percutaneous balloon valvuloplasty may offer similar benefits.
Area of Science:
- Cardiology
- Valvular Heart Disease
Background:
- Mitral stenosis is a common global health issue, prevalent in developing nations and emerging atypically in developed countries.
- This condition significantly contributes to worldwide morbidity.
Purpose of the Study:
- To review the pathology, diagnosis, and treatment of mitral stenosis.
- To discuss the comparative benefits of surgical and percutaneous interventions.
Main Methods:
- Literature review of mitral stenosis pathology, diagnosis, and treatment options.
- Analysis of morbidity and mortality outcomes associated with different treatment modalities.
Main Results:
- All interventions that increase mitral valve area improve patient morbidity.
- Surgical intervention improves mortality; percutaneous balloon valvuloplasty may offer similar mortality benefits, requiring further investigation.
- Percutaneous balloon valvuloplasty is the preferred treatment for indicated patients, including those with suboptimal valve morphology if surgery is not feasible or carries high risk.
Conclusions:
- Effective management of mitral stenosis hinges on increasing valve area, thereby reducing morbidity.
- Percutaneous balloon valvuloplasty is a primary treatment option, with potential mortality benefits comparable to surgery, especially when surgical risks are high.
Related Concept Videos
01:22Mitral Stenosis I: Introduction
Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
01:23Mitral Stenosis II: Clinical features and Diagnostic Tests
Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
01:26Mitral Stenosis III: Medical Management
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
01:27Mitral Stenosis IV: Nursing Management
A comprehensive nursing assessment is essential for patients with valvular heart disease, which involves any dysfunction of the heart valves that could impact blood flow and overall heart function.Subjective Data Collection:Chief Complaint and Present Illness: Start with the patient's primary concerns, focusing on the onset, duration, and progression of cardiac symptoms such as dyspnea, fatigue, chest pain, and palpitations.Past Medical History: Collect detailed information on any previous...
01:20Mitral Regurgitation I: Introduction
Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
01:27Mitral Valve Prolapse I: Introduction
IntroductionThe mitral valve, one of the heart's four valves, regulates blood flow. These valves have flaps that open and close to direct blood properly through the heart and body. During each heartbeat, the flaps open for blood to pass through and seal shut to prevent backflow. Specifically, the mitral valve opens to allow blood flow from the heart's upper left chamber to the lower left chamber. It then closes securely as the lower left chamber contracts to pump blood to the body, preventing...